Dr Karen Cadoo

Karen A. Cadoo is a Medical Oncologist and Cancer Geneticist at St. James’s
Hospital (SJH) and Clinical Associate Professor, Trinity College Dublin, Ireland. She co-leads the inherited cancer genetics programme at SJH and the cancer prevention pillar of the Trinity St. James’s Cancer Institute. She returned to Ireland in 2020 having spent the preceding 8 years at Memorial Sloan Kettering Cancer Center in New York where she was lead for Inherited Gynecologic Cancer Genetics.

Since her return she participates in national policy and service development in her role on the National Cancer Control Programme (NCCP) Hereditary Cancer Steering Group. She contributed to the National Strategy for Genetics and Genomics 2022 and served on the implementation taskforce. She participated in the development of the NCCP Hereditary Model of Care 2023 and is chair of the Hereditary Cancer Working Group for Networked Services. Her research is centered on inherited genetics, drug development and tumor biology.

She has served as principal investigator for multiple therapeutic trials in gynecologic cancers and is co-lead of Cancer Trials Ireland (CTI) Gynecologic Disease Specific Subgroup. She is CTI representative to GCIG board of directors and ENGOT. She was formerly a member of the Niehaus Center for Inherited Cancer Genetics at Memorial Sloan Kettering Cancer Center, New York and she has explored the role of inherited predisposition in gynecologic cancers and across multiple cancer types.

She is a recipient of the Irish Cancer Society 2021 Clinician Research Leadership Award for her research in hereditary cancer genetics and participated in the ASCO Leadership Development Program 2023-2024.